HomeCompareAVVH vs PLD

AVVH vs PLD: Dividend Comparison 2026

AVVH yields 66666.67% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVVH wins by $8.441837856534449e+24M in total portfolio value
10 years
AVVH
AVVH
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full AVVH calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — AVVH vs PLD

📍 AVVH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVVHPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVVH + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVVH pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVVH
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, AVVH beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVVH + PLD for your $10,000?

AVVH: 50%PLD: 50%
100% PLD50/50100% AVVH
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

AVVH
No analyst data
Altman Z
-27.1
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVVH buys
0
PLD buys
0
No recent congressional trades found for AVVH or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVVHPLD
Forward yield66666.67%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$8.441837856534449e+24M$5.91M
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00$4,750,725.19
Total dividends collected$8.44020886744369e+24M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: AVVH vs PLD ($10,000, DRIP)

YearAVVH PortfolioAVVH Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$6,677,367$6,666,666.67$11,241$540.96+$6.67MAVVH
2$4,167,497,846$4,160,353,063.34$13,019$991.13+$4167.48MAVVH
3$2,431,161,901,635$2,426,702,678,939.67$15,801$1,870.97+$2431161.89MAVVH
4$1,325,636,209,022,888$1,323,034,865,788,139.00$20,609$3,701.21+$1325636209.00MAVVH
5$675,632,775,263,916,700$674,214,344,520,262,300.00$29,919$7,867.97+$675632775263.89MAVVH
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$50,631$18,617.74+$321867481182444.19MAVVH
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$105,528$51,352.20+$143326993661751472.00MAVVH
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$287,364$174,449.42+$59657925421851500544.00MAVVH
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$1,081,760$774,280.77+$2.3211471150187796e+22MAVVH
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$5,908,209$4,750,725.19+$8.441837856534449e+24MAVVH

AVVH vs PLD: Complete Analysis 2026

AVVHStock

AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.

Full AVVH Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this AVVH vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVVH vs SCHDAVVH vs JEPIAVVH vs OAVVH vs KOAVVH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.